Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.71 | N/A |
| PEG Ratio (TTM) | -0.48 | N/A |
| P/S Ratio (TTM) | 2.54 | N/A |
| P/B Ratio (TTM) | 1.27 | N/A |
| P/FCF Ratio (TTM) | 3.06 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.39 | N/A |
| Price to 5YR AVG FCF Ratio | 5.05 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.82% | N/A |
| ROE (TTM) | 9.95% | N/A |
| Net Profit Margin (TTM) | 19.94% | N/A |
| ROIC 5YR AVG | 16.79% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.30% | -1.39% | 16.73% |
| Revenue | 21.46% | 15.73% | 16.36% |
| Net Income | -16.55% | 4.22% | 18.60% |
| Cash Flow | 335.35% | 166.00% | 215.20% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.26 | N/A |
| Interest Coverage (TTM) | 0.26 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.36 | N/A |
| LTL to 5YR AVG FCF | 1.57 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.47% | N/A |